Denver startup Intero Biosystems, spun out of the University of Michigan, has launched GastroScreen, a human intestinal organoid model made of multiple cell and tissue types found in the gut. The company ships roughly 100 of the millimeter-sized organoids at a time to pharmaceutical, biotech, food, and chemical companies, which use them to test drugs and compounds in either healthy or disease-induced states. Intero also sells supporting supplies like nutrient mixes and reagents, and runs custom experiments and lab studies for clients.
techcrunch.com
· 2026-10-14
Sanofi and Regeneron have agreed to broaden their existing partnership, with the collaboration potentially worth as much as $8 billion. The companies said they will jointly share development and commercialization costs, as well as any future profits generated by new drugs produced under the expanded agreement.
wsj.com
· 2026-10-01
Chinese pharmaceutical companies, once known mainly for producing cheap generic medicines, are now developing original obesity and weight-loss drugs aimed at competing with Western blockbusters like Ozempic and Wegovy. Several firms are advancing candidates through clinical trials and striking licensing deals with major international drugmakers.
wsj.com
· 2026-09-11
GoKawiil